BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27188504)

  • 1. Defective postreperfusion metabolic recovery directly associates with incident delayed graft function.
    Wijermars LG; Schaapherder AF; de Vries DK; Verschuren L; Wüst RC; Kostidis S; Mayboroda OA; Prins F; Ringers J; Bierau J; Bakker JA; Kooistra T; Lindeman JH
    Kidney Int; 2016 Jul; 90(1):181-91. PubMed ID: 27188504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed graft function and its management in children.
    Grenda R
    Pediatr Nephrol; 2017 Jul; 32(7):1157-1167. PubMed ID: 27778091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary mitochondrial DNA associates with delayed graft function following renal transplantation.
    Jansen MPB; Pulskens WPC; Uil M; Claessen N; Nieuwenhuizen G; Standaar D; Hau CM; Nieuwland R; Florquin S; Bemelman FJ; Leemans JC; Roelofs JJTH
    Nephrol Dial Transplant; 2020 Aug; 35(8):1320-1327. PubMed ID: 30590723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein levels of heme oxygenase-1 during reperfusion in human kidney transplants with delayed graft function.
    Ollinger R; Kogler P; Biebl M; Sieb M; Sucher R; Bösmüller C; Troppmair J; Mark W; Weiss H; Margreiter R
    Clin Transplant; 2008; 22(4):418-23. PubMed ID: 18261117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular atrophy and low netrin-1 gene expression are associated with delayed kidney allograft function.
    Wohlfahrtova M; Brabcova I; Zelezny F; Balaz P; Janousek L; Honsova E; Lodererova A; Wohlfahrt P; Viklicky O
    Transplantation; 2014 Jan; 97(2):176-83. PubMed ID: 24092381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.
    Castellano G; Intini A; Stasi A; Divella C; Gigante M; Pontrelli P; Franzin R; Accetturo M; Zito A; Fiorentino M; Montinaro V; Lucarelli G; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; van Amersfoort E; Pertosa G; Grandaliano G; Gesualdo L
    Am J Transplant; 2016 Jan; 16(1):325-33. PubMed ID: 26280899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Inducible Factor-1α Expression in Kidney Transplant Biopsy Specimens After Reperfusion Is Associated With Early Recovery of Graft Function After Cadaveric Kidney Transplantation.
    Oda T; Ishimura T; Yokoyama N; Ogawa S; Miyake H; Fujisaw M
    Transplant Proc; 2017; 49(1):68-72. PubMed ID: 28104162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cytokine concentrations in graft renal vein during reperfusion in patients with and without delayed graft function.
    Domański L; Pawlik A; Safranow K; Rozański J; Myślak M; Sulikowski T; Romanowski M; Ostrowski M; Wiśniewska M; Domański M; Kabat-Koperska J; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):49-52. PubMed ID: 19127809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypoxanthine-xanthine oxidase axis is not involved in the initial phase of clinical transplantation-related ischemia-reperfusion injury.
    Wijermars LG; Bakker JA; de Vries DK; van Noorden CJ; Bierau J; Kostidis S; Mayboroda OA; Tsikas D; Schaapherder AF; Lindeman JH
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F457-F464. PubMed ID: 28031169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of arteriolar hyalinosis in post-reperfusion biopsies represents an additional risk to ischaemic injury in renal transplant.
    Matos AC; Câmara NO; REQUIãO-Moura LR; Tonato EJ; Filiponi TC; Souza-DURãO M; Malheiros DM; Fregonesi M; Borrelli M; Pacheco-Silva A
    Nephrology (Carlton); 2016 Nov; 21(11):923-929. PubMed ID: 26661292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of an explorative clinical evaluation suggest immediate and persistent post-reperfusion metabolic paralysis drives kidney ischemia reperfusion injury.
    Lindeman JH; Wijermars LG; Kostidis S; Mayboroda OA; Harms AC; Hankemeier T; Bierau J; Sai Sankar Gupta KB; Giera M; Reinders ME; Zuiderwijk MC; Le Dévédec SE; Schaapherder AF; Bakker JA
    Kidney Int; 2020 Dec; 98(6):1476-1488. PubMed ID: 32781105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study.
    Domański L; Kłoda K; Kwiatkowska E; Borowiecka E; Safranow K; Drozd A; Ciechanowicz A; Ciechanowski K
    BMC Nephrol; 2015 Feb; 16():23. PubMed ID: 25884882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative release of pro-regenerative biochemical signals from human renal allografts subjected to ischemia-reperfusion injury.
    Błogowski W; Dolegowska B; Budkowska M; Sałata D; Domański L; Starzynska T
    Innate Immun; 2014 Feb; 20(2):126-32. PubMed ID: 23608824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Gill J; Dong J; Rose C; Gill JS
    Kidney Int; 2016 Jun; 89(6):1331-6. PubMed ID: 27165823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function.
    Heilman RL; Smith ML; Smith BH; Qaqish I; Khamash H; Singer AL; Kaplan B; Reddy KS
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2225-2232. PubMed ID: 27797897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
    Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
    Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
    Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
    Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
    Ponticelli C
    Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function.
    Yu ZX; Qi S; Lasaro MA; Bouchard K; Dow C; Moore K; Wu Z; Barama A; Xu J; Johnson K; Marozsan AJ; Wang Y
    Am J Transplant; 2016 Sep; 16(9):2589-97. PubMed ID: 27003920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion.
    Koo DD; Welsh KI; Roake JA; Morris PJ; Fuggle SV
    Am J Pathol; 1998 Aug; 153(2):557-66. PubMed ID: 9708815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.